Baamonde Ana, Lastra Ana, Villazón María, Bordallo Javier, Hidalgo Agustín, Menéndez Luis
Laboratorio de Farmacología, Facultad de Medicina, Universidad de Oviedo, C/ Julián Clavería 6, 33006 Oviedo, Asturias, Spain.
Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):245-51. doi: 10.1007/s00210-003-0841-1. Epub 2003 Dec 6.
Endothelin receptors have been involved in inflammatory, neuropathic and tumoral pain. In the case of inflammatory hyperalgesia, some previous papers have pointed towards the involvement of ETB receptors, although the stimulation of ETA receptors seems to participate in the development of the inflammatory reaction. We have studied the effect of ETA and ETB receptor antagonists in the thermal and mechanical hyperalgesia induced in a model of acute (induced by carrageenan) and chronic (induced by complete Freund's adjuvant, CFA) inflammation in mice. The i.pl. administration of the selective ETA antagonist BQ-123 (1-10 nmol) antagonized the thermal hyperalgesia detected by the unilateral hot plate test, observed in both inflammatory models, whereas the i.pl. administration of the ETB selective antagonist BQ-788 (17.7 nmol) failed to modify this. In contrast, both BQ-123 (3-17.7 nmol) and BQ-788 (3-17.7 nmol) antagonized the mechanical hyperalgesia, as assessed by the Randall-Selitto test in carrageenan- and CFA-treated mice. Both BQ-123 and BQ-788 were able to antagonize the mechanical hyperalgesia induced by ET-1 (200 pmol; i.pl.) in the same dose range. Thus, ETA receptors are involved in both thermal and mechanical hyperalgesia whereas ETB receptors are only involved in mechanical hyperalgesia in these inflammatory models. In conclusion, the role of ETB receptors in inflammatory pain is further supported and new insights into the participation of ETA receptors in inflammatory hyperalgesia are given.
内皮素受体与炎症性、神经性和肿瘤性疼痛有关。在炎症性痛觉过敏的情况下,一些先前的论文指出ETB受体参与其中,尽管ETA受体的刺激似乎也参与了炎症反应的发展。我们研究了ETA和ETB受体拮抗剂对小鼠急性(由角叉菜胶诱导)和慢性(由完全弗氏佐剂,CFA诱导)炎症模型中诱导的热痛觉过敏和机械性痛觉过敏的影响。腹腔注射选择性ETA拮抗剂BQ-123(1-10 nmol)可拮抗在两种炎症模型中通过单侧热板试验检测到的热痛觉过敏,而腹腔注射ETB选择性拮抗剂BQ-788(17.7 nmol)未能改变这一情况。相反,通过对角叉菜胶和CFA处理的小鼠进行兰德尔-塞利托试验评估,BQ-123(3-17.7 nmol)和BQ-788(3-17.7 nmol)均能拮抗机械性痛觉过敏。在相同剂量范围内,BQ-123和BQ-788均能拮抗ET-1(200 pmol;腹腔注射)诱导的机械性痛觉过敏。因此,在这些炎症模型中,ETA受体参与热痛觉过敏和机械性痛觉过敏,而ETB受体仅参与机械性痛觉过敏。总之,ETB受体在炎症性疼痛中的作用得到了进一步支持,并且对ETA受体参与炎症性痛觉过敏有了新的认识。